These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1353387)

  • 1. Thrombospondin: a new attachment protein in preretinal traction membranes.
    Weller M; Esser P; Bresgen M; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1992; 2(1):10-4. PubMed ID: 1353387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.
    Weller M; Wiedemann P; Bresgen M; Heimann K
    Int Ophthalmol; 1991 Mar; 15(2):93-101. PubMed ID: 1708748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin.
    Hiscott P; Larkin G; Robey HL; Orr G; Grierson I
    Eye (Lond); 1992; 6 ( Pt 6)():566-9. PubMed ID: 1289132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins of the extracellular matrix in vitreoretinal membranes.
    Scheiffarth OF; Kampik A; Günther H; von der Mark K
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(4):357-61. PubMed ID: 3049258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Grisanti S; Heimann K; Wiedemann P
    Br J Ophthalmol; 1993 Apr; 77(4):238-42. PubMed ID: 8494861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy.
    Fredj-Reygrobellet D; Baudouin C; Nègre F; Caruelle JP; Gastaud P; Lapalus P
    Ophthalmic Res; 1991; 23(3):154-61. PubMed ID: 1719460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Kangave D; Siddiquei MM; Ola MS; Opdenakker G
    Acta Diabetol; 2013 Aug; 50(4):545-51. PubMed ID: 21947384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin.
    Jaffe GJ
    Surv Ophthalmol; 1994; 38(4):393-4. PubMed ID: 8160115
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
    Weller M; Clausen R; Bresgen M; Heimann K; Wiedemann P
    Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
    Casaroli Marano RP; Vilaró S
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2791-803. PubMed ID: 7514582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI; Chung H; Lee J
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The build-up of the thrombospondin extracellular matrix. An apparent dependence on synthesis and on preformed fibrillar matrix.
    Dreyfus M; Lahav J
    Eur J Cell Biol; 1988 Dec; 47(2):275-82. PubMed ID: 3072202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen in proliferative vitreoretinal disorders.
    Esser P; Heimann K; Bartz-Schmidt KU; Walter P; Krott R; Weller M
    Br J Ophthalmol; 1997 Jul; 81(7):590-4. PubMed ID: 9290376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.